Veterinary Medicine Information website

Eradia 125 mg/ml, oral suspension for dogs

Authorised
  • Metronidazole
Download as PDF

Product identification

Medicine name:
Eradia 125 mg/ml, oral suspension for dogs
Active substance:
  • Metronidazole
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Metronidazole
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XD01
  • QP51AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • 30 ml presentation: white opaque polyethylene terephthalate (PET) bottle equipped with a sampling polypropylene (PP) snap cap with silicon stopper and a 3 ml polypropylene (PP) syringe placed in a carton box
  • 100 ml presentation: white opaque polyethylene terephthalates (PET) bottle equipped with a sampling Polyethylene (PE) screw cap with PE seal and a 3 ml polypropylene (PP) oral syringe placed in a carton box
  • 30 ml presentation: white opaque polyethylene terephthalate (PET) bottle equipped with a sampling polyethylene (PE) screw cap with PE seal and a 3 ml polypropylene (PP) oral syringe placed in a carton box
  • 100 ml presentation: white opaque polyethylene terephthalate (PET) bottle equipped with a sampling polypropylene (PP) snap cap with silicon stopper and a 3 ml polypropylene (PP) syringe placed in a carton box

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Delpharm Huningue S.A.S.
  • Virbac
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0232/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 13/03/2026
Download
German (PDF)
Published on: 13/03/2026
Download
Dutch (PDF)
Published on: 13/03/2026
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 13/03/2026
Download
German (PDF)
Published on: 13/03/2026
Download
Dutch (PDF)
Published on: 13/03/2026
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 13/03/2026
Download
German (PDF)
Published on: 13/03/2026
Download
Dutch (PDF)
Published on: 13/03/2026
Download

Combined File of all Documents

English (PDF)
Published on: 9/05/2024
Download

Final PuAR Eradia 125 mg-ml oral suspension for dogs_update 05112023.pdf

English (PDF)
Published on: 15/12/2025
Download